 | • レポートコード：GIR201114174 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、糖尿病性末梢神経障害治療の世界市場を調査対象にし、糖尿病性末梢神経障害治療の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（Antimunocel、ASP-8477、BNV-222、カプサイシン、CBX-129801、その他）、用途別分析（病院、クリニック、その他）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Achelios Therapeutics Inc、Mitsubishi Tanabe Pharma Corp、Grunenthal GmbH、Celgene Corp、Medifron DBT Co Ltd、Commence Bio Inc、Reata Pharmaceuticals Inc、KPI Therapeutics Inc、Immune Pharmaceuticals Inc、Novaremed Ltd、Relief Therapeutics Holding AG、ViroMed Co Ltd ・企業別売上、市場シェア ・糖尿病性末梢神経障害治療の地域別市場分析 ・糖尿病性末梢神経障害治療の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・糖尿病性末梢神経障害治療のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・糖尿病性末梢神経障害治療のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・糖尿病性末梢神経障害治療の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・糖尿病性末梢神経障害治療の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・糖尿病性末梢神経障害治療の種類別市場規模2015-2020：Antimunocel、ASP-8477、BNV-222、カプサイシン、CBX-129801、その他 ・糖尿病性末梢神経障害治療の用途別市場規模2015-2020：病院、クリニック、その他 ・糖尿病性末梢神経障害治療の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論 |
Market Overview
The global Diabetic Peripheral Neuropathy Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Diabetic Peripheral Neuropathy Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Diabetic Peripheral Neuropathy Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Diabetic Peripheral Neuropathy Treatment market has been segmented into:
Antimunocel
ASP-8477
BNV-222
Capsaicin
CBX-129801
Others
By Application, Diabetic Peripheral Neuropathy Treatment has been segmented into:
Hospital
Clinic
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Diabetic Peripheral Neuropathy Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Diabetic Peripheral Neuropathy Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Diabetic Peripheral Neuropathy Treatment market.
The report offers in-depth assessment of the growth and other aspects of the Diabetic Peripheral Neuropathy Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Diabetic Peripheral Neuropathy Treatment Market Share Analysis
Diabetic Peripheral Neuropathy Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Diabetic Peripheral Neuropathy Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Diabetic Peripheral Neuropathy Treatment sales, revenue and market share for each player covered in this report.
The major players covered in Diabetic Peripheral Neuropathy Treatment are:
Achelios Therapeutics Inc
Mitsubishi Tanabe Pharma Corp
Grunenthal GmbH
Celgene Corp
Medifron DBT Co Ltd
Commence Bio Inc
Reata Pharmaceuticals Inc
KPI Therapeutics Inc
Immune Pharmaceuticals Inc
Novaremed Ltd
Relief Therapeutics Holding AG
ViroMed Co Ltd
Table of Contents
1 Diabetic Peripheral Neuropathy Treatment Market Overview
1.1 Product Overview and Scope of Diabetic Peripheral Neuropathy Treatment
1.2 Classification of Diabetic Peripheral Neuropathy Treatment by Type
1.2.1 Global Diabetic Peripheral Neuropathy Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Diabetic Peripheral Neuropathy Treatment Revenue Market Share by Type in 2019
1.2.3 Antimunocel
1.2.4 ASP-8477
1.2.5 BNV-222
1.2.6 Capsaicin
1.2.7 CBX-129801
1.2.8 Others
1.3 Global Diabetic Peripheral Neuropathy Treatment Market by Application
1.3.1 Overview: Global Diabetic Peripheral Neuropathy Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Diabetic Peripheral Neuropathy Treatment Market by Regions
1.4.1 Global Diabetic Peripheral Neuropathy Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Diabetic Peripheral Neuropathy Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Diabetic Peripheral Neuropathy Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Diabetic Peripheral Neuropathy Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Diabetic Peripheral Neuropathy Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Diabetic Peripheral Neuropathy Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Diabetic Peripheral Neuropathy Treatment Status and Prospect (2015-2025)
2 Company Profiles
2.1 Achelios Therapeutics Inc
2.1.1 Achelios Therapeutics Inc Details
2.1.2 Achelios Therapeutics Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Achelios Therapeutics Inc SWOT Analysis
2.1.4 Achelios Therapeutics Inc Product and Services
2.1.5 Achelios Therapeutics Inc Diabetic Peripheral Neuropathy Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 Mitsubishi Tanabe Pharma Corp
2.2.1 Mitsubishi Tanabe Pharma Corp Details
2.2.2 Mitsubishi Tanabe Pharma Corp Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Mitsubishi Tanabe Pharma Corp SWOT Analysis
2.2.4 Mitsubishi Tanabe Pharma Corp Product and Services
2.2.5 Mitsubishi Tanabe Pharma Corp Diabetic Peripheral Neuropathy Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Grunenthal GmbH
2.3.1 Grunenthal GmbH Details
2.3.2 Grunenthal GmbH Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Grunenthal GmbH SWOT Analysis
2.3.4 Grunenthal GmbH Product and Services
2.3.5 Grunenthal GmbH Diabetic Peripheral Neuropathy Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 Celgene Corp
2.4.1 Celgene Corp Details
2.4.2 Celgene Corp Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Celgene Corp SWOT Analysis
2.4.4 Celgene Corp Product and Services
2.4.5 Celgene Corp Diabetic Peripheral Neuropathy Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 Medifron DBT Co Ltd
2.5.1 Medifron DBT Co Ltd Details
2.5.2 Medifron DBT Co Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Medifron DBT Co Ltd SWOT Analysis
2.5.4 Medifron DBT Co Ltd Product and Services
2.5.5 Medifron DBT Co Ltd Diabetic Peripheral Neuropathy Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 Commence Bio Inc
2.6.1 Commence Bio Inc Details
2.6.2 Commence Bio Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Commence Bio Inc SWOT Analysis
2.6.4 Commence Bio Inc Product and Services
2.6.5 Commence Bio Inc Diabetic Peripheral Neuropathy Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.7 Reata Pharmaceuticals Inc
2.7.1 Reata Pharmaceuticals Inc Details
2.7.2 Reata Pharmaceuticals Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Reata Pharmaceuticals Inc SWOT Analysis
2.7.4 Reata Pharmaceuticals Inc Product and Services
2.7.5 Reata Pharmaceuticals Inc Diabetic Peripheral Neuropathy Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.8 KPI Therapeutics Inc
2.8.1 KPI Therapeutics Inc Details
2.8.2 KPI Therapeutics Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 KPI Therapeutics Inc SWOT Analysis
2.8.4 KPI Therapeutics Inc Product and Services
2.8.5 KPI Therapeutics Inc Diabetic Peripheral Neuropathy Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.9 Immune Pharmaceuticals Inc
2.9.1 Immune Pharmaceuticals Inc Details
2.9.2 Immune Pharmaceuticals Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Immune Pharmaceuticals Inc SWOT Analysis
2.9.4 Immune Pharmaceuticals Inc Product and Services
2.9.5 Immune Pharmaceuticals Inc Diabetic Peripheral Neuropathy Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.10 Novaremed Ltd
2.10.1 Novaremed Ltd Details
2.10.2 Novaremed Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Novaremed Ltd SWOT Analysis
2.10.4 Novaremed Ltd Product and Services
2.10.5 Novaremed Ltd Diabetic Peripheral Neuropathy Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.11 Relief Therapeutics Holding AG
2.11.1 Relief Therapeutics Holding AG Details
2.11.2 Relief Therapeutics Holding AG Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Relief Therapeutics Holding AG SWOT Analysis
2.11.4 Relief Therapeutics Holding AG Product and Services
2.11.5 Relief Therapeutics Holding AG Diabetic Peripheral Neuropathy Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.12 ViroMed Co Ltd
2.12.1 ViroMed Co Ltd Details
2.12.2 ViroMed Co Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 ViroMed Co Ltd SWOT Analysis
2.12.4 ViroMed Co Ltd Product and Services
2.12.5 ViroMed Co Ltd Diabetic Peripheral Neuropathy Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Diabetic Peripheral Neuropathy Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Diabetic Peripheral Neuropathy Treatment Players Market Share
3.2.2 Top 10 Diabetic Peripheral Neuropathy Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Diabetic Peripheral Neuropathy Treatment Revenue and Market Share by Regions
4.2 North America Diabetic Peripheral Neuropathy Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Diabetic Peripheral Neuropathy Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Diabetic Peripheral Neuropathy Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Diabetic Peripheral Neuropathy Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Diabetic Peripheral Neuropathy Treatment Revenue and Growth Rate (2015-2020)
5 North America Diabetic Peripheral Neuropathy Treatment Revenue by Countries
5.1 North America Diabetic Peripheral Neuropathy Treatment Revenue by Countries (2015-2020)
5.2 USA Diabetic Peripheral Neuropathy Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Diabetic Peripheral Neuropathy Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Diabetic Peripheral Neuropathy Treatment Revenue and Growth Rate (2015-2020)
6 Europe Diabetic Peripheral Neuropathy Treatment Revenue by Countries
6.1 Europe Diabetic Peripheral Neuropathy Treatment Revenue by Countries (2015-2020)
6.2 Germany Diabetic Peripheral Neuropathy Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Diabetic Peripheral Neuropathy Treatment Revenue and Growth Rate (2015-2020)
6.4 France Diabetic Peripheral Neuropathy Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Diabetic Peripheral Neuropathy Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Diabetic Peripheral Neuropathy Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Diabetic Peripheral Neuropathy Treatment Revenue by Countries
7.1 Asia-Pacific Diabetic Peripheral Neuropathy Treatment Revenue by Countries (2015-2020)
7.2 China Diabetic Peripheral Neuropathy Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Diabetic Peripheral Neuropathy Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Diabetic Peripheral Neuropathy Treatment Revenue and Growth Rate (2015-2020)
7.5 India Diabetic Peripheral Neuropathy Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Diabetic Peripheral Neuropathy Treatment Revenue and Growth Rate (2015-2020)
8 South America Diabetic Peripheral Neuropathy Treatment Revenue by Countries
8.1 South America Diabetic Peripheral Neuropathy Treatment Revenue by Countries (2015-2020)
8.2 Brazil Diabetic Peripheral Neuropathy Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Diabetic Peripheral Neuropathy Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Diabetic Peripheral Neuropathy Treatment by Countries
9.1 Middle East & Africa Diabetic Peripheral Neuropathy Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Diabetic Peripheral Neuropathy Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Diabetic Peripheral Neuropathy Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Diabetic Peripheral Neuropathy Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Diabetic Peripheral Neuropathy Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Diabetic Peripheral Neuropathy Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Diabetic Peripheral Neuropathy Treatment Market Forecast by Type (2019-2024)
10.3 Antimunocel Revenue Growth Rate (2015-2025)
10.4 ASP-8477 Revenue Growth Rate (2015-2025)
10.5 BNV-222 Revenue Growth Rate (2015-2025)
10.6 Capsaicin Revenue Growth Rate (2015-2025)
10.7 CBX-129801 Revenue Growth Rate (2015-2025)
10.8 Others Revenue Growth Rate (2015-2025)
11 Global Diabetic Peripheral Neuropathy Treatment Market Segment by Application
11.1 Global Diabetic Peripheral Neuropathy Treatment Revenue Market Share by Application (2015-2020)
11.2 Diabetic Peripheral Neuropathy Treatment Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Clinic Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global Diabetic Peripheral Neuropathy Treatment Market Size Forecast (2021-2025)
12.1 Global Diabetic Peripheral Neuropathy Treatment Market Size Forecast (2021-2025)
12.2 Global Diabetic Peripheral Neuropathy Treatment Market Forecast by Regions (2021-2025)
12.3 North America Diabetic Peripheral Neuropathy Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Diabetic Peripheral Neuropathy Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Diabetic Peripheral Neuropathy Treatment Revenue Market Forecast (2021-2025)
12.6 South America Diabetic Peripheral Neuropathy Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Diabetic Peripheral Neuropathy Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Diabetic Peripheral Neuropathy Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Diabetic Peripheral Neuropathy Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Diabetic Peripheral Neuropathy Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Diabetic Peripheral Neuropathy Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Achelios Therapeutics Inc Corporate Information, Location and Competitors
Table 6. Achelios Therapeutics Inc Diabetic Peripheral Neuropathy Treatment Major Business
Table 7. Achelios Therapeutics Inc Diabetic Peripheral Neuropathy Treatment Total Revenue (USD Million) (2017-2018)
Table 8. Achelios Therapeutics Inc SWOT Analysis
Table 9. Achelios Therapeutics Inc Diabetic Peripheral Neuropathy Treatment Product and Solutions
Table 10. Achelios Therapeutics Inc Diabetic Peripheral Neuropathy Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Mitsubishi Tanabe Pharma Corp Corporate Information, Location and Competitors
Table 12. Mitsubishi Tanabe Pharma Corp Diabetic Peripheral Neuropathy Treatment Major Business
Table 13. Mitsubishi Tanabe Pharma Corp Diabetic Peripheral Neuropathy Treatment Total Revenue (USD Million) (2018-2019)
Table 14. Mitsubishi Tanabe Pharma Corp SWOT Analysis
Table 15. Mitsubishi Tanabe Pharma Corp Diabetic Peripheral Neuropathy Treatment Product and Solutions
Table 16. Mitsubishi Tanabe Pharma Corp Diabetic Peripheral Neuropathy Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Grunenthal GmbH Corporate Information, Location and Competitors
Table 18. Grunenthal GmbH Diabetic Peripheral Neuropathy Treatment Major Business
Table 19. Grunenthal GmbH Diabetic Peripheral Neuropathy Treatment Total Revenue (USD Million) (2017-2018)
Table 20. Grunenthal GmbH SWOT Analysis
Table 21. Grunenthal GmbH Diabetic Peripheral Neuropathy Treatment Product and Solutions
Table 22. Grunenthal GmbH Diabetic Peripheral Neuropathy Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Celgene Corp Corporate Information, Location and Competitors
Table 24. Celgene Corp Diabetic Peripheral Neuropathy Treatment Major Business
Table 25. Celgene Corp Diabetic Peripheral Neuropathy Treatment Total Revenue (USD Million) (2017-2018)
Table 26. Celgene Corp SWOT Analysis
Table 27. Celgene Corp Diabetic Peripheral Neuropathy Treatment Product and Solutions
Table 28. Celgene Corp Diabetic Peripheral Neuropathy Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Medifron DBT Co Ltd Corporate Information, Location and Competitors
Table 30. Medifron DBT Co Ltd Diabetic Peripheral Neuropathy Treatment Major Business
Table 31. Medifron DBT Co Ltd Diabetic Peripheral Neuropathy Treatment Total Revenue (USD Million) (2017-2018)
Table 32. Medifron DBT Co Ltd SWOT Analysis
Table 33. Medifron DBT Co Ltd Diabetic Peripheral Neuropathy Treatment Product and Solutions
Table 34. Medifron DBT Co Ltd Diabetic Peripheral Neuropathy Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Commence Bio Inc Corporate Information, Location and Competitors
Table 36. Commence Bio Inc Diabetic Peripheral Neuropathy Treatment Major Business
Table 37. Commence Bio Inc Diabetic Peripheral Neuropathy Treatment Total Revenue (USD Million) (2017-2018)
Table 38. Commence Bio Inc SWOT Analysis
Table 39. Commence Bio Inc Diabetic Peripheral Neuropathy Treatment Product and Solutions
Table 40. Commence Bio Inc Diabetic Peripheral Neuropathy Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Reata Pharmaceuticals Inc Corporate Information, Location and Competitors
Table 42. Reata Pharmaceuticals Inc Diabetic Peripheral Neuropathy Treatment Major Business
Table 43. Reata Pharmaceuticals Inc Diabetic Peripheral Neuropathy Treatment Total Revenue (USD Million) (2017-2018)
Table 44. Reata Pharmaceuticals Inc SWOT Analysis
Table 45. Reata Pharmaceuticals Inc Diabetic Peripheral Neuropathy Treatment Product and Solutions
Table 46. Reata Pharmaceuticals Inc Diabetic Peripheral Neuropathy Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. KPI Therapeutics Inc Corporate Information, Location and Competitors
Table 48. KPI Therapeutics Inc Diabetic Peripheral Neuropathy Treatment Major Business
Table 49. KPI Therapeutics Inc Diabetic Peripheral Neuropathy Treatment Total Revenue (USD Million) (2017-2018)
Table 50. KPI Therapeutics Inc SWOT Analysis
Table 51. KPI Therapeutics Inc Diabetic Peripheral Neuropathy Treatment Product and Solutions
Table 52. KPI Therapeutics Inc Diabetic Peripheral Neuropathy Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Immune Pharmaceuticals Inc Corporate Information, Location and Competitors
Table 54. Immune Pharmaceuticals Inc Diabetic Peripheral Neuropathy Treatment Major Business
Table 55. Immune Pharmaceuticals Inc Diabetic Peripheral Neuropathy Treatment Total Revenue (USD Million) (2017-2018)
Table 56. Immune Pharmaceuticals Inc SWOT Analysis
Table 57. Immune Pharmaceuticals Inc Diabetic Peripheral Neuropathy Treatment Product and Solutions
Table 58. Immune Pharmaceuticals Inc Diabetic Peripheral Neuropathy Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Novaremed Ltd Corporate Information, Location and Competitors
Table 60. Novaremed Ltd Diabetic Peripheral Neuropathy Treatment Major Business
Table 61. Novaremed Ltd Diabetic Peripheral Neuropathy Treatment Total Revenue (USD Million) (2017-2018)
Table 62. Novaremed Ltd SWOT Analysis
Table 63. Novaremed Ltd Diabetic Peripheral Neuropathy Treatment Product and Solutions
Table 64. Novaremed Ltd Diabetic Peripheral Neuropathy Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Relief Therapeutics Holding AG Corporate Information, Location and Competitors
Table 66. Relief Therapeutics Holding AG Diabetic Peripheral Neuropathy Treatment Major Business
Table 67. Relief Therapeutics Holding AG Diabetic Peripheral Neuropathy Treatment Total Revenue (USD Million) (2017-2018)
Table 68. Relief Therapeutics Holding AG SWOT Analysis
Table 69. Relief Therapeutics Holding AG Diabetic Peripheral Neuropathy Treatment Product and Solutions
Table 70. Relief Therapeutics Holding AG Diabetic Peripheral Neuropathy Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. ViroMed Co Ltd Corporate Information, Location and Competitors
Table 72. ViroMed Co Ltd Diabetic Peripheral Neuropathy Treatment Major Business
Table 73. ViroMed Co Ltd Diabetic Peripheral Neuropathy Treatment Total Revenue (USD Million) (2017-2018)
Table 74. ViroMed Co Ltd SWOT Analysis
Table 75. ViroMed Co Ltd Diabetic Peripheral Neuropathy Treatment Product and Solutions
Table 76. ViroMed Co Ltd Diabetic Peripheral Neuropathy Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Global Diabetic Peripheral Neuropathy Treatment Revenue (Million USD) by Players (2015-2020)
Table 78. Global Diabetic Peripheral Neuropathy Treatment Revenue Share by Players (2015-2020)
Table 79. Global Diabetic Peripheral Neuropathy Treatment Revenue (Million USD) by Regions (2015-2020)
Table 80. Global Diabetic Peripheral Neuropathy Treatment Revenue Market Share by Regions (2015-2020)
Table 81. North America Diabetic Peripheral Neuropathy Treatment Revenue by Countries (2015-2020)
Table 82. North America Diabetic Peripheral Neuropathy Treatment Revenue Market Share by Countries (2015-2020)
Table 83. Europe Diabetic Peripheral Neuropathy Treatment Revenue (Million USD) by Countries (2015-2020)
Table 84. Asia-Pacific Diabetic Peripheral Neuropathy Treatment Revenue (Million USD) by Countries (2015-2020)
Table 85. South America Diabetic Peripheral Neuropathy Treatment Revenue by Countries (2015-2020)
Table 86. South America Diabetic Peripheral Neuropathy Treatment Revenue Market Share by Countries (2015-2020)
Table 87. Middle East and Africa Diabetic Peripheral Neuropathy Treatment Revenue (Million USD) by Countries (2015-2020)
Table 88. Middle East and Africa Diabetic Peripheral Neuropathy Treatment Revenue Market Share by Countries (2015-2020)
Table 89. Global Diabetic Peripheral Neuropathy Treatment Revenue (Million USD) by Type (2015-2020)
Table 90. Global Diabetic Peripheral Neuropathy Treatment Revenue Share by Type (2015-2020)
Table 91. Global Diabetic Peripheral Neuropathy Treatment Revenue Forecast by Type (2021-2025)
Table 92. Global Diabetic Peripheral Neuropathy Treatment Revenue by Application (2015-2020)
Table 93. Global Diabetic Peripheral Neuropathy Treatment Revenue Share by Application (2015-2020)
Table 94. Global Diabetic Peripheral Neuropathy Treatment Revenue Forecast by Application (2021-2025)
Table 95. Global Diabetic Peripheral Neuropathy Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Diabetic Peripheral Neuropathy Treatment Picture
Figure 2. Global Diabetic Peripheral Neuropathy Treatment Revenue Market Share by Type in 2019
Figure 3. Antimunocel Picture
Figure 4. ASP-8477 Picture
Figure 5. BNV-222 Picture
Figure 6. Capsaicin Picture
Figure 7. CBX-129801 Picture
Figure 8. Others Picture
Figure 9. Diabetic Peripheral Neuropathy Treatment Revenue Market Share by Application in 2019
Figure 10. Hospital Picture
Figure 11. Clinic Picture
Figure 12. Others Picture
Figure 13. Global Diabetic Peripheral Neuropathy Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 14. North America Diabetic Peripheral Neuropathy Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Europe Diabetic Peripheral Neuropathy Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Asia-Pacific Diabetic Peripheral Neuropathy Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. South America Diabetic Peripheral Neuropathy Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Middle East and Africa Diabetic Peripheral Neuropathy Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Diabetic Peripheral Neuropathy Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Diabetic Peripheral Neuropathy Treatment Revenue Share by Players in 2019
Figure 21. Global Top 5 Players Diabetic Peripheral Neuropathy Treatment Revenue Market Share in 2019
Figure 22. Global Top 10 Players Diabetic Peripheral Neuropathy Treatment Revenue Market Share in 2019
Figure 23. Key Players Market Share Trend
Figure 24. Global Diabetic Peripheral Neuropathy Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 25. Global Diabetic Peripheral Neuropathy Treatment Revenue Market Share by Regions (2015-2020)
Figure 26. Global Diabetic Peripheral Neuropathy Treatment Revenue Market Share by Regions in 2018
Figure 27. North America Diabetic Peripheral Neuropathy Treatment Revenue and Growth Rate (2015-2020)
Figure 28. Europe Diabetic Peripheral Neuropathy Treatment Revenue and Growth Rate (2015-2020)
Figure 29. Asia-Pacific Diabetic Peripheral Neuropathy Treatment Revenue and Growth Rate (2015-2020)
Figure 30. South America Diabetic Peripheral Neuropathy Treatment Revenue and Growth Rate (2015-2020)
Figure 31. Middle East and Africa Diabetic Peripheral Neuropathy Treatment Revenue and Growth Rate (2015-2020)
Figure 32. North America Diabetic Peripheral Neuropathy Treatment Revenue Market Share by Countries (2015-2020)
Figure 33. North America Diabetic Peripheral Neuropathy Treatment Revenue Market Share by Countries in 2019
Figure 34. USA Diabetic Peripheral Neuropathy Treatment Revenue and Growth Rate (2015-2020)
Figure 35. Canada Diabetic Peripheral Neuropathy Treatment Revenue and Growth Rate (2015-2020)
Figure 36. Mexico Diabetic Peripheral Neuropathy Treatment Revenue and Growth Rate (2015-2020)
Figure 37. Europe Diabetic Peripheral Neuropathy Treatment Revenue Market Share by Countries (2015-2020)
Figure 38. Europe Diabetic Peripheral Neuropathy Treatment Revenue Market Share by Countries in 2019
Figure 39. Germany Diabetic Peripheral Neuropathy Treatment Revenue and Growth Rate (2015-2020)
Figure 40. UK Diabetic Peripheral Neuropathy Treatment Revenue and Growth Rate (2015-2020)
Figure 41. France Diabetic Peripheral Neuropathy Treatment Revenue and Growth Rate (2015-2020)
Figure 42. Russia Diabetic Peripheral Neuropathy Treatment Revenue and Growth Rate (2015-2020)
Figure 43. Italy Diabetic Peripheral Neuropathy Treatment Revenue and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Diabetic Peripheral Neuropathy Treatment Revenue Market Share by Countries (2015-2020)
Figure 45. Asia-Pacific Diabetic Peripheral Neuropathy Treatment Revenue Market Share by Countries in 2019
Figure 46. China Diabetic Peripheral Neuropathy Treatment Revenue and Growth Rate (2015-2020)
Figure 47. Japan Diabetic Peripheral Neuropathy Treatment Revenue and Growth Rate (2015-2020)
Figure 48. Korea Diabetic Peripheral Neuropathy Treatment Revenue and Growth Rate (2015-2020)
Figure 49. India Diabetic Peripheral Neuropathy Treatment Revenue and Growth Rate (2015-2020)
Figure 50. Southeast Asia Diabetic Peripheral Neuropathy Treatment Revenue and Growth Rate (2015-2020)
Figure 51. South America Diabetic Peripheral Neuropathy Treatment Revenue Market Share by Countries (2015-2020)
Figure 52. South America Diabetic Peripheral Neuropathy Treatment Revenue Market Share by Countries in 2019
Figure 53. Brazil Diabetic Peripheral Neuropathy Treatment Revenue and Growth Rate (2015-2020)
Figure 54. Argentina Diabetic Peripheral Neuropathy Treatment Revenue and Growth Rate (2015-2020)
Figure 55. Middle East and Africa Diabetic Peripheral Neuropathy Treatment Revenue Market Share by Countries (2015-2020)
Figure 56. Middle East and Africa Diabetic Peripheral Neuropathy Treatment Revenue Market Share by Countries in 2019
Figure 57. Saudi Arabia Diabetic Peripheral Neuropathy Treatment Revenue and Growth Rate (2015-2020)
Figure 58. UAE Diabetic Peripheral Neuropathy Treatment Revenue and Growth Rate (2015-2020)
Figure 59. Egypt Diabetic Peripheral Neuropathy Treatment Revenue and Growth Rate (2015-2020)
Figure 60. South Africa Diabetic Peripheral Neuropathy Treatment Revenue and Growth Rate (2015-2020)
Figure 61. Global Diabetic Peripheral Neuropathy Treatment Revenue Share by Type (2015-2020)
Figure 62. Global Diabetic Peripheral Neuropathy Treatment Revenue Share by Type in 2019
Figure 63. Global Diabetic Peripheral Neuropathy Treatment Market Share Forecast by Type (2021-2025)
Figure 64. Global Antimunocel Revenue Growth Rate (2015-2020)
Figure 65. Global ASP-8477 Revenue Growth Rate (2015-2020)
Figure 66. Global BNV-222 Revenue Growth Rate (2015-2020)
Figure 67. Global Capsaicin Revenue Growth Rate (2015-2020)
Figure 68. Global CBX-129801 Revenue Growth Rate (2015-2020)
Figure 69. Global Others Revenue Growth Rate (2015-2020)
Figure 70. Global Diabetic Peripheral Neuropathy Treatment Revenue Share by Application (2015-2020)
Figure 71. Global Diabetic Peripheral Neuropathy Treatment Revenue Share by Application in 2019
Figure 72. Global Diabetic Peripheral Neuropathy Treatment Market Share Forecast by Application (2021-2025)
Figure 73. Global Hospital Revenue Growth Rate (2015-2020)
Figure 74. Global Clinic Revenue Growth Rate (2015-2020)
Figure 75. Global Others Revenue Growth Rate (2015-2020)
Figure 76. Global Diabetic Peripheral Neuropathy Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 77. Global Diabetic Peripheral Neuropathy Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 78. Global Diabetic Peripheral Neuropathy Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 79. North America Diabetic Peripheral Neuropathy Treatment Revenue Market Forecast (2021-2025)
Figure 80. Europe Diabetic Peripheral Neuropathy Treatment Revenue Market Forecast (2021-2025)
Figure 81. Asia-Pacific Diabetic Peripheral Neuropathy Treatment Revenue Market Forecast (2021-2025)
Figure 82. South America Diabetic Peripheral Neuropathy Treatment Revenue Market Forecast (2021-2025)
Figure 83. Middle East and Africa Diabetic Peripheral Neuropathy Treatment Revenue Market Forecast (2021-2025)
Figure 84. Sales Channel: Direct Channel vs Indirect Channel
化学療法誘発末梢神経障害治療の世界市場 2020年 Market Overview The Chemotherapy Induced Peripheral Neuropathy Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market pla…- 神経障害スクリーニング装置の世界市場 2020年 Market Overview The global Neuropathy Screening Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Neuropathy Scree…
- 視神経症治療薬の世界市場 2020年 Market Overview The global Optic Neuropathy Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Optic Neuropathy Drug m…
- レーバー遺伝性視神経症治療薬の世界市場 2020年 Market Overview The global Leber's Hereditary Optic Neuropathy Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Lebe…
- 糖尿病性ケトアシドーシス治療の世界市場 2020年 Market Overview The global Diabetic Ketoacidosis Treatments market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Diabetic Ket…